(MENAFN- Straits Research)
E-Prescribing Market Size & Growth Analysis
The global e-prescribing market size was valued at USD 5.71 billion in 2025 and is projected to grow from USD 7.10 billion in 2026 to USD 40.50 billion by 2034, registering a CAGR of 24.32% during the forecast period from 2026 to 2034. North America dominated the e-prescribing market with a market share of 42.5% in 2025.
E-prescribing (electronic prescribing) is the use of digital systems to create, transmit, and manage prescriptions electronically between healthcare providers and pharmacies. It helps reduce medication errors, improves prescription accuracy, and enhances patient safety. E-prescribing systems can also support medication history review, drug interaction alerts, formulary checks, and faster prescription processing, improving overall efficiency in healthcare delivery.
E-Prescribing Market Key Takeaways
Global Market Size & Growth
2025 Market Size: USD 5.71 Billion
2026 Market Size: USD 7.10 Billion
2034 Projected Market Size: USD 40.50 Billion
Forecast Period: 2026–2034
Base Year: 2025
Market CAGR (2026–2034): 24.32%
Regional Insights
Largest Regional Market (2025): North America
North America Market Share (2025): 42.5%
Fastest-Growing Region: Europe
Europe CAGR (2026–2034): 16.4%
Segment Insights
By Product
Leading Segment: Integrated Solutions
Market Share in 2025: 34.6%
By Delivery Mode
Fastest-Growing Segment: Web-based
CAGR: 15.1% (2026–2034)
By Usage Method
Leading Segment: Handheld
Market Share in 2025: 46.7%
By Prescription Type
Fastest-Growing Segment: Controlled Substance
CAGR: 15.7% (2026–2034)
By Specialties
Leading Segment: Cardiology
Market Share in 2025: 24.1%
By End-Users
Fastest-Growing Segment: Office-Based Physicians
CAGR: 15.3% (2026–2034)
Download a Free Sample To learn more about this report,
E-Prescribing Market Trends
Shift Toward FHIR-Based Interoperable e-Prescribing Networks
The e-prescribing market analysis indicates that demand for seamless exchange of prescription and patient data across EHRs, pharmacies, and payers is shifting e-prescribing toward FHIR-based interoperable networks, allowing medication information to move through standardized APIs rather than isolated systems; as of July 2026, CMS-aligned networks are required to support FHIR APIs using standardized medication terminology such as RxNorm.
Development of AI-Assisted Prescription Order Generation
Advances in generative AI and clinical decision-support technologies are also supporting AI-assisted prescription order generation, where patient and medication data can help clinicians create and review orders with greater consistency; a 2026 randomized study of 77 pharmacists and trainees found that AI assistance increased overall medication-order verification accuracy, although incorrect AI recommendations also created a risk of automation bias.
E-Prescribing Market Dynamics
Market Drivers
Rising Demand for Medication Error Reduction and Increasing Adoption of Electronic Health Records Drive Market
The rising demand for medication error reduction is increasing adoption of e-prescribing systems that improve prescription accuracy and reduce manual transcription risks. Electronic prescriptions provide structured medication details, dosage instructions, and patient information, supporting safer prescribing workflows. For example, electronic prescribing can flag potential drug interactions or duplicate medications before an order reaches the pharmacy. Higher focus on medication safety increases demand from hospitals, clinics, and pharmacies for reliable e-prescribing platforms. This need for safer medication management therefore supports growth in the e-prescribing market.
The increasing adoption of electronic health records is expanding demand for e-prescribing systems that connect medication orders with digital patient records. Integrated prescribing workflows allow clinicians to access medication histories and record new prescriptions within the same clinical environment. For example, a physician can review a patient's current medications in an EHR before sending a prescription electronically to a pharmacy. Greater EHR adoption encourages healthcare providers to procure connected prescribing capabilities and expands the addressable user base for e-prescribing vendors. This integration of prescribing with digital clinical workflows therefore supports market growth.
Market Restraints
High Implementation and Software Costs and Complex Integration with Existing EHR Systems Restrain Market Expansion
High costs for software licenses, system configuration, customization, training, and ongoing maintenance can create a substantial financial burden for healthcare providers. These expenses can be difficult for smaller practices and facilities with limited technology budgets to manage. Such cost barriers can delay implementation and limit adoption of e prescribing systems.
Compatibility issues between e prescribing platforms and existing EHR systems can make implementation technically complex. Additional integration, customization, and data-mapping requirements can increase deployment time and operational costs. These challenges can disrupt existing workflows and slow adoption across healthcare facilities.
Market Opportunities
Expansion of E-Prescribing in Specialty Pharmacy and Growth of E-Prescribing for Veterinary Care Offer Growth Opportunities
Specialty pharmacies, healthcare providers, and e-prescribing software companies can address complex medication workflows for oncology, autoimmune, and rare-disease treatments. Companies such as Surescripts can generate additional revenue through specialty pharmacy connectivity, prescription routing, and related transaction services.
Veterinary clinics, animal-health providers, and veterinary pharmacy platforms can use electronic prescriptions to streamline medication ordering, refills, and pharmacy coordination. Companies such as Covetrus can expand revenue through veterinary pharmacy services, prescription-management platforms, and related digital solutions.
Market Challenges
Cybersecurity and Prescription Fraud Risks and Medication Availability and Pharmacy Fulfillment Constraints Hinders Growth
The expansion of electronic prescribing creates additional exposure to identity misuse and fraudulent prescription activity, requiring stronger authentication and monitoring. The U.S. DEA reported an increase in fraudulent e-prescriptions between 2021 and 2023, including misuse of prescriber registration numbers and identities, increasing compliance and security requirements for providers.
E-prescribing can transmit prescriptions efficiently, but shortages of specific medicines can still prevent pharmacies from fulfilling them, limiting the practical value of digital prescribing. For example, the U.S. stimulant shortage beginning in 2022 created fulfillment constraints despite continued electronic prescribing, requiring prescribers and pharmacies to manage alternative medicines and availability.
E-Prescribing Market Segmentation
By Product
The integrated solutions segment accounted for a share of 34.6% in 2025, owing to their ability to connect e-prescribing with broader healthcare information systems and support coordinated clinical workflows. The standalone solutions segment provides focused prescribing capabilities, while the services segment supports system deployment and ongoing operational requirements. The implementation segment facilitates system integration and deployment, the training segment supports user adoption, and the network segment enables connectivity among healthcare stakeholders.
The integrated solutions segment is expected to grow at a CAGR of 15.2% during the forecast period 2026-2034, driven by increasing demand for connected healthcare workflows and integration with clinical information systems. The standalone solutions, services, implementation, training, and network segments continue to support different operational and infrastructure requirements within e-prescribing systems.
Request Customization to receive a tailored report.
By Delivery Mode
The web-based segment accounted for a share of 68.2% in 2025, owing to its accessibility, centralized deployment capabilities, and suitability for connecting healthcare providers with digital prescribing platforms. The on-premise segment provides organizations with locally hosted e-prescribing infrastructure and greater control over system deployment and data management.
The web-based segment is expected to grow at a CAGR of 15.1% during the forecast period 2026-2034, driven by increasing adoption of cloud-enabled healthcare technologies and demand for accessible digital prescribing platforms. The on-premise segment continues to serve healthcare organizations requiring locally managed e-prescribing systems.
By Usage Method
The computer based devices segment accounted for a share of 53.3% in 2025, owing to the widespread use of desktop and workstation-based systems across clinical environments. The handheld segment supports mobile prescribing workflows and enables healthcare professionals to access e-prescribing functions through portable devices.
The handheld segment is expected to grow at a CAGR of 15.8% during the forecast period 2026-2034, driven by increasing demand for mobile clinical workflows, point-of-care access, and flexible prescribing capabilities. The computer based devices segment continues to support prescribing activities across established healthcare IT environments.
By Prescription Type
The non-controlled substances segment accounted for a share of 62.1% in 2025, owing to the broad range of routine medications prescribed through digital healthcare systems. The controlled substance segment supports the electronic prescribing of regulated medications and requires additional authentication, security, and compliance measures.
The controlled substance segment is expected to grow at a CAGR of 15.7% during the forecast period 2026-2034, driven by increasing adoption of secure electronic prescribing workflows for regulated medications and growing emphasis on prescription monitoring and compliance. The non-controlled substances segment continues to support routine medication prescribing across healthcare settings.
By Specialties
The others segment accounted for a share of 29.2% in 2025, supported by the broad use of e-prescribing across medical specialties beyond the major categories covered in the market segmentation. The cardiology segment supports medication management in cardiovascular care, while the oncology segment addresses prescribing requirements associated with cancer treatment. The neurology segment supports medication workflows for neurological conditions, while the sports medicine segment serves prescribing needs associated with musculoskeletal and sports-related care.
The cardiology segment is expected to grow at a CAGR of 15.5% during the forecast period 2026-2034, driven by increasing digitalization of cardiovascular care and demand for efficient medication management. The oncology, neurology, sports medicine, and others segments continue to contribute to e-prescribing adoption across specialized clinical workflows.
By End-Users
The hospitals segment accounted for a share of 44.7% in 2025, owing to the high volume of prescriptions, established healthcare IT infrastructure, and need for coordinated medication workflows across hospital departments. The office-based physicians segment supports prescribing within outpatient clinical practices, while the pharmacies segment facilitates medication dispensing and coordination within the prescription ecosystem.
The office-based physicians segment is expected to grow at a CAGR of 15.3% during the forecast period 2026-2034, driven by increasing adoption of digital clinical workflows and demand for efficient prescribing processes in outpatient settings. The hospitals and pharmacies segments continue to support e-prescribing through institutional and medication-dispensing workflows.
Speak to an Analyst to discuss market opportunities.
E-Prescribing Market Regional Outlook
North America E-Prescribing Market Analysis
The North America e prescribing market accounted for the largest regional share of 42.5% in 2025. The region's market is supported by high adoption of electronic prescribing, with 92% of U.S. prescribers already e-prescribing, while CMS requires the updated NCPDP SCRIPT standard for Medicare Part D e-prescribing from January 1, 2028, strengthening interoperability and electronic prescription workflows.
The United States e prescribing market is expected to see further standardization of electronic prescription workflows, as CMS requires the NCPDP SCRIPT 2023011 standard from January 1, 2028, while the NCPDP Formulary and Benefit Standard 60 and Real-Time Prescription Benefit standard 13 will become mandatory for relevant Medicare Part D transactions from 2027, supporting wider interoperability and electronic prescribing adoption. The Canada e prescribing market is expected to expand as Health Canada plans to support the release of pan-Canadian e-prescribing standards to integrate existing digital health systems, with planned federal contributions of CAD 52 million annually in 2026–27, 2027–28, and 2028–29 supporting connected-care initiatives that include e-prescribing.
Unlock Regional Insights to access country-level data, & regional trends.
Europe E-Prescribing Market Analysis
The Europe e prescribing market is expected to grow at a CAGR of 16.4% during the forecast period 2026–2034, showcasing the fastest-growing regional market. The European Commission targets 100% of EU citizens having access to electronic health records by 2030, while the European Health Data Space requires ePrescription and eDispensation exchanges to become operational across all EU Member States by March 2029, strengthening demand for interoperable electronic prescribing systems.
The UK e prescribing market is expected to expand as NHS England targets deployment of the Electronic Prescription Service across all relevant care settings by the end of 2027/28, alongside a broader digital medicines programme designed to create a single national prescribing and dispensing approach. The Germany e prescribing market is expected to broaden as the country progressively extends electronic prescribing beyond medicines, while the federal digitalisation strategy targets 100% electronic transmission of medical reports by the end of 2027 and the e-prescription ecosystem is being integrated with the electronic patient record and other digital healthcare services. The France e prescribing market is expected to advance with the European Health Data Space framework, under which key provisions begin applying from spring 2027, followed by further requirements in 2029 and beyond, while France is preparing the required national regulatory and technical adaptations to enable interoperable digital health-data and prescription services.
Asia Pacific E-Prescribing Market Analysis
The Asia Pacific e prescribing market accounted for a regional share of 20.1% in 2025. The region's digital health infrastructure is expanding, with WHO reporting rapid development of digital health systems across the Western Pacific and emphasizing interoperability, digital health solutions, and stronger digital infrastructure as priorities for future health-system transformation, supporting the wider adoption of electronic prescribing and connected medication-management systems.
The Japan e prescribing market is expected to expand as Japan targets electronic prescription adoption across medical institutions by 2030, with the Ministry of Health, Labour and Welfare reporting that adoption reached 41.3% of eligible facilities in June 2026, while pharmacy adoption reached 90.5%, indicating substantial scope for further implementation among healthcare providers. The China e prescribing market is supported by the country's 2030 digital-health targets, which call for interoperable health-information platforms across national, provincial, municipal, and county levels by 2030, with standardized electronic health records and health cards for the population, strengthening the infrastructure required for electronic prescription exchange and online medication services.
The South Korea e prescribing market is positioned for broader interoperability as the Ministry of Health and Welfare continues developing standardized healthcare-data exchange using HL7 FHIR, while the country's Health Plan 2030 runs through 2030 and targets a rise in healthy life expectancy from 70.4 years in 2018 to 73.3 years by 2030, supporting continued digitalization of healthcare and medication-management services. The India e prescribing market is supported by the expansion of interoperable digital-health infrastructure under the Ayushman Bharat Digital Mission, with new initiatives launched in 2026 to strengthen digital public infrastructure and connected health networks, while the national digital-health framework continues to expand electronic health records and standardized health-data exchange across healthcare providers.
Competitive Landscape
The e-prescribing market is moderately fragmented, with participation from electronic health record (EHR) providers, healthcare information technology companies, pharmacy technology providers, clinical software companies, and specialized e-prescribing solution developers. The leading players in the global e-prescribing market are Epic Systems Corporation, Cerner Corporation, Allscripts Healthcare, LLC., NXGN Management, LLC., and athenahealth, Inc.; publicly available data does not provide a reliable cumulative market share for these exact five companies, although Epic alone accounts for approximately 5.17% of global e-prescribing market revenue.
Established players compete primarily on platform reliability, interoperability, regulatory compliance, prescription accuracy, integration with EHR and pharmacy systems, data security, and relationships with healthcare providers and institutions. Emerging and regional players in the e-prescribing market ecosystem compete through cloud-based platforms, user-friendly interfaces, mobile capabilities, workflow automation, AI-enabled decision support, flexible deployment models, and cost-efficient solutions.
List of Key and Emerging Players in E-Prescribing Market
Epic Systems Corporation (U.S.)
Cerner Corporation (U.S.)
Allscripts Healthcare, LLC. (U.S.)
NXGN Management, LLC. (U.S.)
athenahealth, Inc. (U.S.)
RelayHealth, LLC (U.S.)
Henry Schein, Inc. (U.S.)
General Electric (U.S.)
CPSI (U.S.)
DrFirst (U.S.)
Medical Information Technology, Inc. (U.S.)
eClinicalWorks (U.S.)
Key Industry Developments
April 2026: Surescripts expanded its e-prescribing network by introducing AI-powered prescription decision support, enhanced medication history services, and real-time prescription benefit capabilities for healthcare providers.
February 2026: Oracle Health (formerly Cerner) launched upgraded e-prescribing solutions integrated with AI-assisted clinical workflows, electronic health records (EHRs), and pharmacy connectivity.
October 2025: Epic Systems Corporation expanded its e-prescribing platform with enhanced medication management, electronic prior authorization (ePA), and interoperability features supporting hospital and ambulatory care providers.
June 2025: athenahealth introduced enhanced cloud-based e-prescribing capabilities with integrated clinical decision support, medication adherence tools, and pharmacy workflow automation.
Report Scope
Comments
No comment